<SEC-DOCUMENT>0001209191-15-085951.txt : 20151217
<SEC-HEADER>0001209191-15-085951.hdr.sgml : 20151217
<ACCEPTANCE-DATETIME>20151217202106
ACCESSION NUMBER:		0001209191-15-085951
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20141215
FILED AS OF DATE:		20151217
DATE AS OF CHANGE:		20151217

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Dolby Laboratories, Inc.
		CENTRAL INDEX KEY:			0001308547
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		IRS NUMBER:				900199783
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0924

	BUSINESS ADDRESS:	
		STREET 1:		1275 MARKET STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103
		BUSINESS PHONE:		415 558 0200

	MAIL ADDRESS:	
		STREET 1:		1275 MARKET STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BERGERON MICHAEL
		CENTRAL INDEX KEY:			0001556582

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32431
		FILM NUMBER:		151295054

	MAIL ADDRESS:	
		STREET 1:		C/O DOLBY LABORATORIES, INC.
		STREET 2:		1275 MARKET STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>doc4a.xml
<DESCRIPTION>FORM 4/A SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4/A</documentType>

    <periodOfReport>2014-12-15</periodOfReport>

    <dateOfOriginalSubmission>2014-12-17</dateOfOriginalSubmission>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001308547</issuerCik>
        <issuerName>Dolby Laboratories, Inc.</issuerName>
        <issuerTradingSymbol>DLB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001556582</rptOwnerCik>
            <rptOwnerName>BERGERON MICHAEL</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O DOLBY LABORATORIES, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>1275 MARKET STREET</rptOwnerStreet2>
            <rptOwnerCity>SAN FRANCISCO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94103</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>SVP, WW Sales and Field Oper.</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Employee Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>42.98</value>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2014-12-15</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>72374</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0.00</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2024-12-15</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Class A Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>72374</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>72374</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Due to an administrative error, the exercise price reported on the Form 4 previously filed on December 17, 2014 was $44.14, instead of $42.98.</footnote>
        <footnote id="F2">This option was granted for a total of 72,374 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Daniel Rodriguez, Attorney-in-Fact for Michael Bergeron</signatureName>
        <signatureDate>2015-12-17</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
